Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Director Declaration

15 Jun 2021 07:40

RNS Number : 9206B
Balfour Beatty PLC
15 June 2021
 

 

 

DIRECTOR DECLARATION

15 June 2021

In accordance with Listing Rule 9.6.14R (2), Balfour Beatty plc ("Balfour Beatty"), the international infrastructure group, announces that Barbara Moorhouse, Independent Non-Executive Director of Balfour Beatty, will be appointed as the Senior Independent Non-Executive Director and Chair of the Audit Committee of Medica Group Plc with effect from 1 July 2021.

 

 

Analyst/investor enquiries:

Angus BarryTel. +44 (0)7966 281 635angus.barry@balfourbeatty.com

 

Media enquiries: 

Antonia WaltonTel. +44 (0) 7966 929 633antonia.walton@balfourbeatty.com

 

Notes to editors:

· Balfour Beatty is a leading international infrastructure group with 26,000 employees driving the delivery of powerful new solutions, shaping thinking, creating skylines and inspiring a new generation of talent to be the change-makers of tomorrow.

· We finance, develop, build, maintain and operate the increasingly complex and critical infrastructure that supports national economies and deliver projects at the heart of local communities.

· Over the last 112 years we have created iconic buildings and infrastructure all over the world including: the £1.5 billion A14 improvement scheme - Britain's biggest road project; Hong Kong's HK$5.5 billion world-class harbour theatre project for the West Kowloon Cultural District Authority; and the 12.5 mile $429 million North Metro Commuter Rail line in Colorado, US.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGPUBWQUPGUQA
Date   Source Headline
27th Apr 202311:34 amRNSForm 8.3 - Medica Group Plc
27th Apr 202311:34 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
27th Apr 202311:32 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202311:29 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202310:39 amRNSForm 8.3 - Medica Group Plc
27th Apr 202310:05 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
27th Apr 20239:17 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:16 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:12 amRNSForm 8.3 - Medica Group plc
27th Apr 20238:45 amRNSForm 8.3 - Medica Group Plc
26th Apr 202311:46 amGNWRule 8.3 - Medica Group Plc
26th Apr 20239:47 amRNSForm 8.3 - Medica Group PLC
26th Apr 20239:14 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
25th Apr 20233:20 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - MEDICA GROUP PLC
25th Apr 202312:05 pmRNSForm 8.3 - Medica Group plc
25th Apr 202311:55 amRNSForm 8.3 - Medica Group plc
25th Apr 202311:54 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:52 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:30 amRNSForm 8.3 - Medica Group PLC
25th Apr 20239:49 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
25th Apr 20239:45 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
24th Apr 20232:42 pmRNSForm 8.3 - Medica Group plc
24th Apr 20237:00 amRNSRECOMMENDED CASH ACQUISITION OF MEDICA GROUP PLC
29th Mar 20237:00 amRNSResults for the year ended 31 December 2022
22nd Mar 20237:00 amRNSNotice of Results
14th Mar 202311:39 amRNSHolding(s) in Company
13th Mar 202312:22 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
23rd Feb 202312:23 pmRNSHolding(s) in Company
22nd Feb 20234:42 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSTrading update for FY22 and outlook for FY23
12th Jan 202311:15 amRNSDirector Declaration
9th Jan 20232:38 pmRNSHolding(s) in Company
4th Jan 20231:42 pmRNSIssue of Equity, Block Listing Six Monthly Return
2nd Dec 20222:48 pmRNSHolding(s) in Company
11th Nov 20221:28 pmRNSHolding(s) in Company
10th Nov 20222:09 pmRNSDirector/PDMR Shareholding
8th Nov 20221:35 pmRNSHolding(s) in Company
8th Nov 20221:25 pmRNSDirector/PDMR Shareholding
8th Nov 20221:24 pmRNSDirector/PDMR Shareholding
2nd Nov 20221:49 pmRNSHolding(s) in Company
31st Oct 202212:06 pmRNSHolding(s) in Company
21st Oct 20223:26 pmRNSDirector/PDMR Shareholding
5th Oct 20221:47 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.